97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00268164 (ClinicalTrials.gov)	June 2004	21/12/2005	Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis	Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis	Ulcerative Colitis	Drug: lactobacilus acidophilus & bifidobacterium animalis/lactis	Hvidovre University Hospital	Chr Hansen A/S	Terminated	18 Years	N/A	Both	48	Phase 2	Denmark
2	NCT00374725 (ClinicalTrials.gov)	February 2003	7/9/2006	Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.	Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus. A Randomised Placebo Controlled Trial	Ulcerative Colitis	Behavioral: Administration of probiotic (L. rhamnosus and L. acidophilus)	Odense University Hospital	University of Southern Denmark;Crohn's and Colitis Foundation	Completed	18 Years	N/A	Both	130	N/A	Denmark